Stephen Ronan Ferguson
Chief Executive Officer at Medix Biochemica Oy Ab
Stephen Ronan Ferguson active positions
| Companies | Position | Start | End |
|---|---|---|---|
Medix Biochemica Oy Ab
 Medix Biochemica Oy Ab Medical SpecialtiesHealth Technology Medix Biochemica Oy Ab develops, produces, and markets monoclonal antibodies, antibody services, and recombinant antigens for in vitro diagnostics industry. It also provides rapid tests for human healthcare. The company was founded in 1985 and is headquartered in Espoo, Finland. | Chief Executive Officer | 31/12/2019 | - |
Diaclone SAS
 Diaclone SAS BiotechnologyHealth Technology Part of Medix Biochemica Group Oy, Diaclone SAS is a French company that specializes in clinical immunology and cell diagnoses. The company is based in Besançon, France. Diaclone was acquired by Medix Biochemica Oy Ab from Biotech Investissement SAS on July 13, 2021. | Chairman | 27/07/2021 | - |
Medix Biochemica Group Oy
 Medix Biochemica Group Oy BiotechnologyHealth Technology Medix Biochemica Group Oy engages in business and management consultancy activities. The company was founded on January 23, 2018 and is headquartered in Helsinki, Finland. | Chief Executive Officer | 31/12/2019 | - |
Career history of Stephen Ronan Ferguson
Statistics
International
| Finland | 3 |
| France | 2 |
Operational
| Chief Executive Officer | 2 |
| Chairman | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Medix Biochemica Oy Ab
Medix Biochemica Oy Ab Medical SpecialtiesHealth Technology Medix Biochemica Oy Ab develops, produces, and markets monoclonal antibodies, antibody services, and recombinant antigens for in vitro diagnostics industry. It also provides rapid tests for human healthcare. The company was founded in 1985 and is headquartered in Espoo, Finland. | Health Technology |
Diaclone SAS
Diaclone SAS BiotechnologyHealth Technology Part of Medix Biochemica Group Oy, Diaclone SAS is a French company that specializes in clinical immunology and cell diagnoses. The company is based in Besançon, France. Diaclone was acquired by Medix Biochemica Oy Ab from Biotech Investissement SAS on July 13, 2021. | Health Technology |
Medix Biochemica Group Oy
Medix Biochemica Group Oy BiotechnologyHealth Technology Medix Biochemica Group Oy engages in business and management consultancy activities. The company was founded on January 23, 2018 and is headquartered in Helsinki, Finland. | Health Technology |